MARKET

SCLX

SCLX

Scilex Holding Co
NASDAQ
15.32
-0.07
-0.45%
Opening 11:42 12/18 EST
OPEN
15.39
PREV CLOSE
15.39
HIGH
15.73
LOW
15.21
VOLUME
19.86K
TURNOVER
--
52 WEEK HIGH
34.27
52 WEEK LOW
3.600
MARKET CAP
130.09M
P/E (TTM)
-0.4617
1D
5D
1M
3M
1Y
5Y
1D
Scilex Secures $100M Loan Facility Agreement
TipRanks · 1d ago
Scilex Holding Secures Up to $100 Million Non-Recourse Loan from St. James Bank & Trust
Reuters · 1d ago
Scilex files to sell 1.7M shares of common stock for holders
TipRanks · 2d ago
Weekly Report: what happened at SCLX last week (1208-1212)?
Weekly Report · 3d ago
Scilex Holding Increases Loan Agreement to $100 Million
TipRanks · 5d ago
Scilex Secures $100M Non-Recourse Loan From St. James Bank, Pledges 85.8M Datavault Shares As Collateral
Benzinga · 5d ago
SCILEX HOLDING CO - LOAN AGREEMENT PRINCIPAL AMOUNT INCREASED TO $100 MLN - SEC FILING
Reuters · 5d ago
SCILEX HOLDING CO: AMOUNT OF PLEDGED SECURITIES WAS INCREASED TO 85.8 MLN SHARES OF COMMON STOCK OF DATAVAULT
Reuters · 5d ago
More
About SCLX
Scilex Holding Company is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company’s commercial products include ZTlidoO (lidocaine topical system) 1.8% for the relief of neuropathic pain associated with postherpetic neuralgia (PHN); ELYXYB, a ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults; and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. In addition, it focuses on product candidates, including SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXAO), an epidural injections formulation to treat lumbosacral radicular pain, or sciatica; SP-103 (lidocaine topical system) 5.4%, a ZTlido formulation, for the treatment of acute pain; and SP-104 (4.5 mg, low-dose naltrexone hydrochloride delayed-release capsules) (SP-104) for fibromyalgia treatment.

Webull offers Scilex Holding Co stock information, including NASDAQ: SCLX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SCLX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SCLX stock methods without spending real money on the virtual paper trading platform.